You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,006,745


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,006,745
Title: Device for delivering an aerosol
Abstract:A device for delivering an aerosol comprises a casing member, a valve stem, and a sealing member, wherein the sealing member comprises a thermoplastic elastomer comprising of a copolymer of about 80-95 mole % ethylene and about 5-20 mole % of at least one comonomer wherein the comonomer(s) are 1-butene, 1-hexene, or 1-octene. The device is used with pharmaceutical formulations containing 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane as the propellant.
Inventor(s): Marecki; Paul E. (May Township, County of Washington, MN)
Assignee: Minnesota Mining and Manufacturing Company (St. Paul, MN)
Application Number:08/443,355
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,006,745: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent attorneys, and businesses alike. This article delves into the details of United States Patent 6,006,745, examining its claims, scope, and the broader patent landscape.

Background of the Patent

United States Patent 6,006,745, though not directly provided in the sources, can be analyzed using general principles of patent law and the structure of patent documents. Patents typically include a detailed description of the invention, claims, and background information.

Claims in a Patent

Definition and Importance

Patent claims are the heart of a patent, defining the scope of protection granted to the inventor. They are legal statements that describe the invention and distinguish it from prior art[3].

Types of Claims

  • Independent Claims: These claims stand alone and do not rely on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims build upon independent claims and narrow down the scope by adding additional features or limitations[3].

Claim Count and Length

The number and length of claims can indicate the complexity and breadth of the patent. Recent trends show a standardization in claim counts, with a median and mean of around 16-17 claims per patent. This standardization is driven by USPTO fee structures and professional patent prosecution practices[2].

Scope of the Patent

Measuring Patent Scope

Patent scope can be measured using metrics such as independent claim length and independent claim count. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Examination Process

The examination process tends to narrow the scope of patent claims. Longer examination durations result in more significant narrowing of claim scope in terms of both claim length and count[3].

Patent Landscape

Historical Trends

Historically, there has been a rise in the median claim count from 7 claims in the 1970s-80s to around 17 claims today. The mean claim count has also shown growth, although it dropped from the highs in the early 2000s when many patents had hundreds of claims[2].

Standardization and Professionalization

The reduction in variance in claim counts from the mid-2000s to today suggests that patent drafting has become more standardized. This is likely due to USPTO fee structures and the professionalization of patent prosecution practices[2].

Economic and Legal Implications

Patent Quality and Innovation

The quality of patents, including their scope and claims, affects innovation. Overly broad patents can increase licensing and litigation costs, diminishing incentives for innovation. Narrower, clearer claims are generally associated with higher patent quality[3].

Forward Citations and Maintenance Payments

Patents with narrower claims tend to have more forward citations and require fewer maintenance payments, indicating their relevance and validity[3].

Data and Research

USPTO Datasets

The USPTO provides detailed datasets on patent claims, including information on claim language, dependency relationships, and document-level statistics. These datasets are crucial for analyzing trends and metrics related to patent scope[5].

Case Study: Analyzing a Patent

To analyze a specific patent like 6,006,745, one would typically:

  • Review the independent and dependent claims.
  • Examine the claim length and count.
  • Look at the background and description sections to understand the invention.
  • Check for any amendments or changes during the examination process.

Industry Expert Insights

Industry experts often emphasize the importance of clear and narrow claims. For example, "Narrower claims at publication are associated with a higher probability of grant and a shorter examination process," highlighting the strategic importance of claim drafting[3].

Illustrative Statistics

  • The median claim count has risen from 7 in the 1970s-80s to 17 today.
  • The standard deviation in claim counts has reduced from about 15 in the mid-2000s to around 7 today[2].

Examples and Analogies

Consider a patent as a map defining the boundaries of an inventor's territory. The claims are the precise coordinates that demarcate this territory. Just as clear and precise coordinates are essential for navigation, clear and narrow claims are crucial for defining the scope of a patent.

Key Takeaways

  • Claims Define Scope: Patent claims are the legal boundaries of an invention.
  • Standardization: Recent trends show a standardization in claim counts due to USPTO fee structures and professional practices.
  • Narrower Claims: Narrower claims are associated with higher grant probabilities and shorter examination processes.
  • Economic Impact: Patent quality, including scope and claims, affects innovation and licensing costs.

FAQs

What is the typical number of claims in a patent?

The median and mean claim count is around 16-17 claims per patent, reflecting current trends towards standardization[2].

How does the examination process affect patent claims?

The examination process tends to narrow the scope of patent claims, with longer durations resulting in more significant narrowing[3].

What metrics are used to measure patent scope?

Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope[3].

Why are narrower claims preferred?

Narrower claims are associated with higher grant probabilities, shorter examination processes, and lower maintenance costs, indicating higher patent quality[3].

Where can I find detailed data on patent claims?

The USPTO provides comprehensive datasets on patent claims, including claim language and document-level statistics[5].

Citations

  1. United States Patent and Trademark Office: Patent Claims Research Dataset.
  2. PatentlyO: Patent Claim Count.
  3. Hoover Institution: Patent Claims and Patent Scope.
  4. Justia Patents: Compositions and methods for treating and preventing lung disease.
  5. USPTO: Patent Claims Research Dataset Documentation.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,006,745

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,006,745

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4576096 ⤷  Subscribe
Australia 5075596 ⤷  Subscribe
Australia 665938 ⤷  Subscribe
Australia 694606 ⤷  Subscribe
Australia 9167991 ⤷  Subscribe
Canada 2098727 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.